| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |